Experience

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the initial public offering by iRhythm Technologies, Inc. iRhythm sold 7,238,235 shares…

Davis Polk advised the underwriter, financial adviser and sponsor in connection with the underwritten renounceable rights offering of 48,110,637 new ordinary shares by Remgro Limited. The…

Davis Polk advised the lead dealer managers in connection with cash tender offers by Rio Tinto Finance (USA) plc and Rio Tinto Finance (USA) Limited to purchase certain of their…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $2.5 billion aggregate principal amount of floating-rate senior notes due 2023.  The Davis…

Davis Polk advised the joint bookrunners on the Rule 144A/Regulation S secondary offering of units, which consisted of common and preferred shares, of Transmissora Aliança de Energia…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2021 issued by Export Development Canada. Export…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered notes offering by NIKE, Inc., consisting of $1 billion aggregate principal amount of its 2…

Davis Polk advised the underwriters in connection with the SEC-registered Schedule B debt offerings by KEXIM of $750 million aggregate principal amount of its floating-rate notes due 2019, …

Davis Polk is advising Qatalyst Partners as financial adviser to Everyday Health, Inc. in connection with its $465 million acquisition by Ziff Davis, LLC, which comprises the Digital Media…

Davis Polk advised Sumitomo Mitsui Banking Corporation (SMBC) in connection with a global medium-term note program update and a benchmark takedown, which consisted of $500 million aggregate…